SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ITI'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1M17_A_AQ4A999_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	ALA A 719 LEU A 764 THR A 766 LEU A 768 GLY A 772 LEU A 820 THR A 830	ITI A 1 (-2.9A) ITI A 1 ( 4.2A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) ITI A 1 (-4.6A) ITI A 1 (-3.8A)	1.00A	1m17A-3lzbA: 34.0	1m17A-3lzbA: 86.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1M17_A_AQ4A999_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	ALA A 719 THR A 766 LEU A 768 GLY A 772 LEU A 820 THR A 830 ASP A 831	ITI A 1 (-2.9A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.83A	1m17A-3lzbA: 34.0	1m17A-3lzbA: 86.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1M17_A_AQ4A999_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 694 ALA A 719 THR A 766 LEU A 768 GLY A 772 THR A 830 ASP A 831	ITI A 1 (-3.9A) ITI A 1 (-2.9A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.96A	1m17A-3lzbA: 34.0	1m17A-3lzbA: 86.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	12 / 12	ALA A 719 MET A 742 THR A 766 GLY A 772 CYH A 773 LEU A 775 ASP A 776 ARG A 779 LEU A 820 THR A 830 ASP A 831 PHE A 832	ITI A 1 (-2.9A) ITI A 1 (-3.4A) ITI A 1 (-3.8A) ITI A 1 (-3.5A) ITI A 1 (-4.8A) None None None ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A)	0.75A	1xkkA-3lzbA: 38.3	1xkkA-3lzbA: 87.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	LEU A 694 VAL A 702 CYH A 751 LEU A 753 LEU A 768 MET A 769	ITI A 1 (-3.9A) ITI A 1 (-4.8A) ITI A 1 (-3.7A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-4.8A)	1.14A	1xkkA-3lzbA: 38.3	1xkkA-3lzbA: 87.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	LEU A 694 VAL A 702 LEU A 753 LEU A 764 LEU A 768 MET A 769	ITI A 1 (-3.9A) ITI A 1 (-4.8A) ITI A 1 (-3.8A) ITI A 1 ( 4.2A) ITI A 1 (-4.8A) ITI A 1 (-4.8A)	0.93A	1xkkA-3lzbA: 38.3	1xkkA-3lzbA: 87.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	LEU A 694 VAL A 702 LYS A 721 LEU A 753 LEU A 764 LEU A 768	ITI A 1 (-3.9A) ITI A 1 (-4.8A) ITI A 1 (-2.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.2A) ITI A 1 (-4.8A)	0.81A	1xkkA-3lzbA: 38.3	1xkkA-3lzbA: 87.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	VAL A 702 CYH A 751 LEU A 753 LEU A 768 MET A 769 LEU A 834	ITI A 1 (-4.8A) ITI A 1 (-3.7A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-4.8A) None	1.19A	1xkkA-3lzbA: 38.3	1xkkA-3lzbA: 87.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	VAL A 702 LEU A 753 LEU A 764 LEU A 768 MET A 769 LEU A 834	ITI A 1 (-4.8A) ITI A 1 (-3.8A) ITI A 1 ( 4.2A) ITI A 1 (-4.8A) ITI A 1 (-4.8A) None	1.01A	1xkkA-3lzbA: 38.3	1xkkA-3lzbA: 87.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	VAL A 702 LYS A 721 LEU A 753 LEU A 764 LEU A 768 LEU A 834	ITI A 1 (-4.8A) ITI A 1 (-2.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.2A) ITI A 1 (-4.8A) None	0.95A	1xkkA-3lzbA: 38.3	1xkkA-3lzbA: 87.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITO_A_IREA2020_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 694 ALA A 719 LEU A 764 THR A 766 GLY A 772 ASP A 776 LEU A 820 THR A 830	ITI A 1 (-3.9A) ITI A 1 (-2.9A) ITI A 1 ( 4.2A) ITI A 1 (-3.8A) ITI A 1 (-3.5A) None ITI A 1 (-4.6A) ITI A 1 (-3.8A)	0.89A	2itoA-3lzbA: 34.0	2itoA-3lzbA: 87.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITZ_A_IREA2021_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 694 ALA A 719 THR A 766 GLY A 772 ASP A 776 LEU A 820 THR A 830 ASP A 831	ITI A 1 (-3.9A) ITI A 1 (-2.9A) ITI A 1 (-3.8A) ITI A 1 (-3.5A) None ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.76A	2itzA-3lzbA: 34.3	2itzA-3lzbA: 87.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITZ_A_IREA2021_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 694 VAL A 702 ALA A 719 THR A 766 ASP A 776 LEU A 820 THR A 830 ASP A 831	ITI A 1 (-3.9A) ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-3.8A) None ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.87A	2itzA-3lzbA: 34.3	2itzA-3lzbA: 87.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITZ_A_IREA2021_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	3 / 3	LEU A 764 LEU A 768 MET A 769	ITI A 1 ( 4.2A) ITI A 1 (-4.8A) ITI A 1 (-4.8A)	0.62A	2itzA-3lzbA: 34.3	2itzA-3lzbA: 87.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ROX_B_T44B128_1 (TRANSTHYRETIN)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	LYS A 704 LEU A 694 ALA A 719 THR A 766	None ITI A 1 (-3.9A) ITI A 1 (-2.9A) ITI A 1 (-3.8A)	1.10A	2roxB-3lzbA: undetectable	2roxB-3lzbA: 16.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_B_FMMB91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	11 / 12	ALA A 719 MET A 742 LEU A 753 THR A 766 LEU A 768 GLY A 772 LEU A 820 THR A 830 ASP A 831 PHE A 832 LEU A 834	ITI A 1 (-2.9A) ITI A 1 (-3.4A) ITI A 1 (-3.8A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A) None	0.92A	3bbtB-3lzbA: 37.8	3bbtB-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_B_FMMB91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	11 / 12	VAL A 702 ALA A 719 MET A 742 LEU A 753 THR A 766 LEU A 768 LEU A 820 THR A 830 ASP A 831 PHE A 832 LEU A 834	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-3.4A) ITI A 1 (-3.8A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A) None	0.92A	3bbtB-3lzbA: 37.8	3bbtB-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	ALA A 719 LEU A 764 GLY A 772 LEU A 820 THR A 830 ASP A 831 PHE A 832 LEU A 834	ITI A 1 (-2.9A) ITI A 1 ( 4.2A) ITI A 1 (-3.5A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A) None	0.88A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	ALA A 719 LEU A 764 THR A 766 GLY A 772 LEU A 820 THR A 830 ASP A 831 PHE A 832	ITI A 1 (-2.9A) ITI A 1 ( 4.2A) ITI A 1 (-3.8A) ITI A 1 (-3.5A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A)	0.91A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	ALA A 719 MET A 742 GLY A 772 LEU A 820 THR A 830 ASP A 831 PHE A 832 LEU A 834	ITI A 1 (-2.9A) ITI A 1 (-3.4A) ITI A 1 (-3.5A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A) None	1.07A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	ALA A 719 MET A 742 THR A 766 GLY A 772 LEU A 820 THR A 830 ASP A 831 PHE A 832	ITI A 1 (-2.9A) ITI A 1 (-3.4A) ITI A 1 (-3.8A) ITI A 1 (-3.5A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A)	1.03A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	VAL A 702 ALA A 719 LEU A 764 LEU A 820 THR A 830 ASP A 831 PHE A 832 LEU A 834	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 ( 4.2A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A) None	0.84A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	VAL A 702 ALA A 719 LEU A 764 THR A 766 LEU A 820 THR A 830 ASP A 831 PHE A 832	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 ( 4.2A) ITI A 1 (-3.8A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A)	0.87A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A 702 ALA A 719 LYS A 721 LEU A 764 ASP A 831 PHE A 832 LEU A 834	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 ( 4.2A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A) None	1.03A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A 702 ALA A 719 LYS A 721 LEU A 764 THR A 766 ASP A 831 PHE A 832	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 ( 4.2A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A)	1.04A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	VAL A 702 ALA A 719 MET A 742 LEU A 820 THR A 830 ASP A 831 PHE A 832 LEU A 834	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-3.4A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A) None	1.04A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	VAL A 702 ALA A 719 MET A 742 THR A 766 LEU A 820 THR A 830 ASP A 831 PHE A 832	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-3.4A) ITI A 1 (-3.8A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) ITI A 1 (-3.6A)	1.00A	3bbtD-3lzbA: 37.8	3bbtD-3lzbA: 69.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 8	ALA A 719 LEU A 764 THR A 766 LEU A 768 MET A 769	ITI A 1 (-2.9A) ITI A 1 ( 4.2A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-4.8A)	0.82A	3lfaA-3lzbA: 19.2	3lfaA-3lzbA: 23.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 8	ALA A 719 LYS A 721 LEU A 764 THR A 766 LEU A 768	ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 ( 4.2A) ITI A 1 (-3.8A) ITI A 1 (-4.8A)	0.44A	3lfaA-3lzbA: 19.2	3lfaA-3lzbA: 23.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_1 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	GLY A 697 GLY A 700 VAL A 702 ALA A 719 LEU A 723 LEU A 820 ASP A 831	None None ITI A 1 (-4.8A) ITI A 1 (-2.9A) None ITI A 1 (-4.6A) ITI A 1 ( 4.6A)	1.13A	3v5wA-3lzbA: 7.5	3v5wA-3lzbA: 16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_1 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	GLY A 697 GLY A 700 VAL A 702 ALA A 719 LYS A 721 LEU A 723 ASP A 831	None None ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) None ITI A 1 ( 4.6A)	1.11A	3v5wA-3lzbA: 7.5	3v5wA-3lzbA: 16.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	ALA A 719 THR A 766 MET A 769 GLY A 772 CYH A 773 LEU A 820 THR A 830 ASP A 831	ITI A 1 (-2.9A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) ITI A 1 (-4.8A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.95A	4hjoA-3lzbA: 38.7	4hjoA-3lzbA: 88.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	VAL A 702 ALA A 719 THR A 766 MET A 769 CYH A 773 LEU A 820 THR A 830 ASP A 831	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-4.8A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	1.03A	4hjoA-3lzbA: 38.7	4hjoA-3lzbA: 88.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LMN_A_EUIA503_1 (DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	LYS A 721 ASN A 818 ASP A 831 PHE A 832 GLY A 833	ITI A 1 (-2.6A) None ITI A 1 ( 4.6A) ITI A 1 (-3.6A) None	0.92A	4lmnA-3lzbA: 24.5	4lmnA-3lzbA: 23.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WA9_A_AXIA9000_1 (TYROSINE-PROTEIN KINASE ABL1)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 11	LEU A 694 ALA A 719 THR A 766 GLY A 772 ASN A 818 LEU A 820	ITI A 1 (-3.9A) ITI A 1 (-2.9A) ITI A 1 (-3.8A) ITI A 1 (-3.5A) None ITI A 1 (-4.6A)	0.68A	4wa9A-3lzbA: 28.4	4wa9A-3lzbA: 34.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WKQ_A_IREA1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	ALA A 719 LEU A 764 THR A 766 LEU A 768 GLY A 772 ASP A 776 LEU A 820 THR A 830	ITI A 1 (-2.9A) ITI A 1 ( 4.2A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) None ITI A 1 (-4.6A) ITI A 1 (-3.8A)	0.88A	4wkqA-3lzbA: 34.6	4wkqA-3lzbA: 86.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WKQ_A_IREA1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 694 ALA A 719 LEU A 764 THR A 766 LEU A 768 GLY A 772 ASP A 776	ITI A 1 (-3.9A) ITI A 1 (-2.9A) ITI A 1 ( 4.2A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) None	0.98A	4wkqA-3lzbA: 34.6	4wkqA-3lzbA: 86.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WKQ_A_IREA1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 753 THR A 766 LEU A 768 GLY A 772 ASP A 776 LEU A 820 THR A 830	ITI A 1 (-3.8A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) None ITI A 1 (-4.6A) ITI A 1 (-3.8A)	1.42A	4wkqA-3lzbA: 34.6	4wkqA-3lzbA: 86.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XOY_A_DX4A401_0 (MITOGEN-ACTIVATED PROTEIN KINASE 1)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	ALA A 719 LEU A 768 MET A 769 LEU A 820	ITI A 1 (-2.9A) ITI A 1 (-4.8A) ITI A 1 (-4.8A) ITI A 1 (-4.6A)	0.88A	4xoyA-3lzbA: 20.7	4xoyA-3lzbA: 22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP3_A_DX4A401_0 (MITOGEN-ACTIVATED PROTEIN KINASE 1)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	ALA A 719 LEU A 768 MET A 769 LEU A 820	ITI A 1 (-2.9A) ITI A 1 (-4.8A) ITI A 1 (-4.8A) ITI A 1 (-4.6A)	0.81A	4xp3A-3lzbA: 21.0	4xp3A-3lzbA: 22.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_A_1N1A501_1 (PROTEIN-TYROSINE KINASE 6)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	LEU A 694 ALA A 719 THR A 766 LEU A 768 GLY A 772 LEU A 820	ITI A 1 (-3.9A) ITI A 1 (-2.9A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) ITI A 1 (-4.6A)	0.90A	5h2uA-3lzbA: 32.1	5h2uA-3lzbA: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_A_1N1A501_1 (PROTEIN-TYROSINE KINASE 6)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 694 VAL A 702 ALA A 719 LYS A 721 THR A 766 LEU A 768 LEU A 820	ITI A 1 (-3.9A) ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-4.6A)	0.91A	5h2uA-3lzbA: 32.1	5h2uA-3lzbA: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_B_1N1B501_1 (PROTEIN-TYROSINE KINASE 6)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 694 ALA A 719 THR A 766 LEU A 768 GLY A 772 LEU A 820 ASP A 831	ITI A 1 (-3.9A) ITI A 1 (-2.9A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-3.5A) ITI A 1 (-4.6A) ITI A 1 ( 4.6A)	1.00A	5h2uB-3lzbA: 32.3	5h2uB-3lzbA: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_B_1N1B501_1 (PROTEIN-TYROSINE KINASE 6)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 694 VAL A 702 ALA A 719 LYS A 721 THR A 766 LEU A 768 LEU A 820 ASP A 831	ITI A 1 (-3.9A) ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 (-3.8A) ITI A 1 (-4.8A) ITI A 1 (-4.6A) ITI A 1 ( 4.6A)	0.99A	5h2uB-3lzbA: 32.3	5h2uB-3lzbA: 30.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_C_P06C801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	GLY A 695 VAL A 702 ALA A 719 LYS A 721 THR A 766	ITI A 1 ( 4.8A) ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 (-3.8A)	0.58A	5hieC-3lzbA: 26.5	5hieC-3lzbA: 27.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	GLY A 695 GLY A 697 LYS A 721 LEU A 723	ITI A 1 ( 4.8A) None ITI A 1 (-2.6A) None	0.77A	5izfA-3lzbA: 20.4	5izfA-3lzbA: 22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 7	GLY A 695 GLY A 697 GLY A 700 VAL A 702 LEU A 723	ITI A 1 ( 4.8A) None None ITI A 1 (-4.8A) None	0.76A	5izjB-3lzbA: 20.1	5izjB-3lzbA: 22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	GLY A 695 GLY A 697 VAL A 702 LYS A 721	ITI A 1 ( 4.8A) None ITI A 1 (-4.8A) ITI A 1 (-2.6A)	0.44A	5izjA-3lzbA: 20.2	5izjA-3lzbA: 22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 9	GLY A 695 VAL A 702 ALA A 719 LEU A 768 LEU A 820	ITI A 1 ( 4.8A) ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-4.8A) ITI A 1 (-4.6A)	0.92A	5lw1H-3lzbA: 19.3	5lw1H-3lzbA: 12.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MAF_A_XINA403_2 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 5	LEU A 753 CYH A 751 LEU A 820 ASP A 831	ITI A 1 (-3.8A) ITI A 1 (-3.7A) ITI A 1 (-4.6A) ITI A 1 ( 4.6A)	1.46A	5mafA-3lzbA: 22.9	5mafA-3lzbA: 11.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YU9_A_1E8A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	10 / 12	LEU A 694 GLY A 695 VAL A 702 ALA A 719 LYS A 721 MET A 742 LEU A 764 CYH A 773 THR A 830 ASP A 831	ITI A 1 (-3.9A) ITI A 1 ( 4.8A) ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 (-3.4A) ITI A 1 ( 4.2A) ITI A 1 (-4.8A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.79A	5yu9A-3lzbA: 39.0	5yu9A-3lzbA: 95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YU9_A_1E8A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	10 / 12	LEU A 694 GLY A 695 VAL A 702 ALA A 719 MET A 742 LEU A 764 CYH A 773 LEU A 820 THR A 830 ASP A 831	ITI A 1 (-3.9A) ITI A 1 ( 4.8A) ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-3.4A) ITI A 1 ( 4.2A) ITI A 1 (-4.8A) ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.76A	5yu9A-3lzbA: 39.0	5yu9A-3lzbA: 95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YU9_B_1E8B1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	11 / 12	GLY A 695 VAL A 702 ALA A 719 LYS A 721 MET A 742 LEU A 764 CYH A 773 ASP A 776 LEU A 820 THR A 830 ASP A 831	ITI A 1 ( 4.8A) ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 (-3.4A) ITI A 1 ( 4.2A) ITI A 1 (-4.8A) None ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.69A	5yu9B-3lzbA: 38.9	5yu9B-3lzbA: 95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YU9_C_1E8C1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	9 / 12	ALA A 719 LYS A 721 MET A 742 LEU A 764 GLY A 772 CYH A 773 ASP A 776 THR A 830 ASP A 831	ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 (-3.4A) ITI A 1 ( 4.2A) ITI A 1 (-3.5A) ITI A 1 (-4.8A) None ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.76A	5yu9C-3lzbA: 38.9	5yu9C-3lzbA: 95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YU9_C_1E8C1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	LEU A 753 GLY A 772 CYH A 773 ASP A 776 THR A 830 ASP A 831	ITI A 1 (-3.8A) ITI A 1 (-3.5A) ITI A 1 (-4.8A) None ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	1.29A	5yu9C-3lzbA: 38.9	5yu9C-3lzbA: 95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YU9_C_1E8C1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	9 / 12	VAL A 702 ALA A 719 LYS A 721 MET A 742 LEU A 764 CYH A 773 ASP A 776 THR A 830 ASP A 831	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 (-3.4A) ITI A 1 ( 4.2A) ITI A 1 (-4.8A) None ITI A 1 (-3.8A) ITI A 1 ( 4.6A)	0.75A	5yu9C-3lzbA: 38.9	5yu9C-3lzbA: 95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YU9_D_1E8D1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	10 / 12	ALA A 719 LYS A 721 MET A 742 GLY A 772 CYH A 773 ASP A 776 LEU A 820 THR A 830 ASP A 831 LEU A 834	ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 (-3.4A) ITI A 1 (-3.5A) ITI A 1 (-4.8A) None ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) None	0.79A	5yu9D-3lzbA: 39.0	5yu9D-3lzbA: 95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YU9_D_1E8D1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	10 / 12	VAL A 702 ALA A 719 LYS A 721 MET A 742 CYH A 773 ASP A 776 LEU A 820 THR A 830 ASP A 831 LEU A 834	ITI A 1 (-4.8A) ITI A 1 (-2.9A) ITI A 1 (-2.6A) ITI A 1 (-3.4A) ITI A 1 (-4.8A) None ITI A 1 (-4.6A) ITI A 1 (-3.8A) ITI A 1 ( 4.6A) None	0.80A	5yu9D-3lzbA: 39.0	5yu9D-3lzbA: 95.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1M17_A_AQ4A999_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"ALA A 719;LEU A 764;THR A 766;LEU A 768;GLY A 772;LEU A 820;THR A 830","ITI A   1 (-2.9A);ITI A   1 ( 4.2A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);ITI A   1 (-4.6A);ITI A   1 (-3.8A)","1.00A","1m17A-3lzbA:34.0",null],["1M17_A_AQ4A999_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"ALA A 719;THR A 766;LEU A 768;GLY A 772;LEU A 820;THR A 830;ASP A 831","ITI A   1 (-2.9A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.83A","1m17A-3lzbA:34.0","1m17A-3lzbA:86.19"],["1M17_A_AQ4A999_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 694;ALA A 719;THR A 766;LEU A 768;GLY A 772;THR A 830;ASP A 831","ITI A   1 (-3.9A);ITI A   1 (-2.9A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.96A","1m17A-3lzbA:34.0","1m17A-3lzbA:86.19"],["1XKK_A_FMMA91_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",12,"ALA A 719;MET A 742;THR A 766;GLY A 772;CYH A 773;LEU A 775;ASP A 776;ARG A 779;LEU A 820;THR A 830;ASP A 831;PHE A 832","ITI A   1 (-2.9A);ITI A   1 (-3.4A);ITI A   1 (-3.8A);ITI A   1 (-3.5A);ITI A   1 (-4.8A);None;None;None;ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A)","0.75A","1xkkA-3lzbA:38.3","1m17A-3lzbA:86.19"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 694;VAL A 702;CYH A 751;LEU A 753;LEU A 768;MET A 769","ITI A   1 (-3.9A);ITI A   1 (-4.8A);ITI A   1 (-3.7A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-4.8A)","1.14A","1xkkA-3lzbA:38.3","1xkkA-3lzbA:87.77"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 694;VAL A 702;LEU A 753;LEU A 764;LEU A 768;MET A 769","ITI A   1 (-3.9A);ITI A   1 (-4.8A);ITI A   1 (-3.8A);ITI A   1 ( 4.2A);ITI A   1 (-4.8A);ITI A   1 (-4.8A)","0.93A","1xkkA-3lzbA:38.3","1xkkA-3lzbA:87.77"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 694;VAL A 702;LYS A 721;LEU A 753;LEU A 764;LEU A 768","ITI A   1 (-3.9A);ITI A   1 (-4.8A);ITI A   1 (-2.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.2A);ITI A   1 (-4.8A)","0.81A","1xkkA-3lzbA:38.3","1xkkA-3lzbA:87.77"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A 702;CYH A 751;LEU A 753;LEU A 768;MET A 769;LEU A 834","ITI A   1 (-4.8A);ITI A   1 (-3.7A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-4.8A);None","1.19A","1xkkA-3lzbA:38.3","1xkkA-3lzbA:87.77"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A 702;LEU A 753;LEU A 764;LEU A 768;MET A 769;LEU A 834","ITI A   1 (-4.8A);ITI A   1 (-3.8A);ITI A   1 ( 4.2A);ITI A   1 (-4.8A);ITI A   1 (-4.8A);None","1.01A","1xkkA-3lzbA:38.3","1xkkA-3lzbA:87.77"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A 702;LYS A 721;LEU A 753;LEU A 764;LEU A 768;LEU A 834","ITI A   1 (-4.8A);ITI A   1 (-2.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.2A);ITI A   1 (-4.8A);None","0.95A","1xkkA-3lzbA:38.3","1xkkA-3lzbA:87.77"],["2ITO_A_IREA2020_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 694;ALA A 719;LEU A 764;THR A 766;GLY A 772;ASP A 776;LEU A 820;THR A 830","ITI A   1 (-3.9A);ITI A   1 (-2.9A);ITI A   1 ( 4.2A);ITI A   1 (-3.8A);ITI A   1 (-3.5A);None;ITI A   1 (-4.6A);ITI A   1 (-3.8A)","0.89A","2itoA-3lzbA:34.0","1xkkA-3lzbA:87.77"],["2ITZ_A_IREA2021_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 694;ALA A 719;THR A 766;GLY A 772;ASP A 776;LEU A 820;THR A 830;ASP A 831","ITI A   1 (-3.9A);ITI A   1 (-2.9A);ITI A   1 (-3.8A);ITI A   1 (-3.5A);None;ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.76A","2itzA-3lzbA:34.3","2itoA-3lzbA:87.46"],["2ITZ_A_IREA2021_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 694;VAL A 702;ALA A 719;THR A 766;ASP A 776;LEU A 820;THR A 830;ASP A 831","ITI A   1 (-3.9A);ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-3.8A);None;ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.87A","2itzA-3lzbA:34.3","2itzA-3lzbA:87.46"],["2ITZ_A_IREA2021_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",3,"LEU A 764;LEU A 768;MET A 769","ITI A   1 ( 4.2A);ITI A   1 (-4.8A);ITI A   1 (-4.8A)","0.62A","2itzA-3lzbA:34.3","2itzA-3lzbA:87.46"],["2ROX_B_T44B128_1","TRANSTHYRETIN","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",4,"LYS A 704;LEU A 694;ALA A 719;THR A 766","None;ITI A   1 (-3.9A);ITI A   1 (-2.9A);ITI A   1 (-3.8A)","1.10A","2roxB-3lzbA:undetectable","2itzA-3lzbA:87.46"],["3BBT_B_FMMB91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",11,"ALA A 719;MET A 742;LEU A 753;THR A 766;LEU A 768;GLY A 772;LEU A 820;THR A 830;ASP A 831;PHE A 832;LEU A 834","ITI A   1 (-2.9A);ITI A   1 (-3.4A);ITI A   1 (-3.8A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A);None","0.92A","3bbtB-3lzbA:37.8","2roxB-3lzbA:16.46"],["3BBT_B_FMMB91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",11,"VAL A 702;ALA A 719;MET A 742;LEU A 753;THR A 766;LEU A 768;LEU A 820;THR A 830;ASP A 831;PHE A 832;LEU A 834","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-3.4A);ITI A   1 (-3.8A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A);None","0.92A","3bbtB-3lzbA:37.8","3bbtB-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"ALA A 719;LEU A 764;GLY A 772;LEU A 820;THR A 830;ASP A 831;PHE A 832;LEU A 834","ITI A   1 (-2.9A);ITI A   1 ( 4.2A);ITI A   1 (-3.5A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A);None","0.88A","3bbtD-3lzbA:37.8","3bbtB-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"ALA A 719;LEU A 764;THR A 766;GLY A 772;LEU A 820;THR A 830;ASP A 831;PHE A 832","ITI A   1 (-2.9A);ITI A   1 ( 4.2A);ITI A   1 (-3.8A);ITI A   1 (-3.5A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A)","0.91A","3bbtD-3lzbA:37.8","3bbtD-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"ALA A 719;MET A 742;GLY A 772;LEU A 820;THR A 830;ASP A 831;PHE A 832;LEU A 834","ITI A   1 (-2.9A);ITI A   1 (-3.4A);ITI A   1 (-3.5A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A);None","1.07A","3bbtD-3lzbA:37.8","3bbtD-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"ALA A 719;MET A 742;THR A 766;GLY A 772;LEU A 820;THR A 830;ASP A 831;PHE A 832","ITI A   1 (-2.9A);ITI A   1 (-3.4A);ITI A   1 (-3.8A);ITI A   1 (-3.5A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A)","1.03A","3bbtD-3lzbA:37.8","3bbtD-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"VAL A 702;ALA A 719;LEU A 764;LEU A 820;THR A 830;ASP A 831;PHE A 832;LEU A 834","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 ( 4.2A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A);None","0.84A","3bbtD-3lzbA:37.8","3bbtD-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"VAL A 702;ALA A 719;LEU A 764;THR A 766;LEU A 820;THR A 830;ASP A 831;PHE A 832","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 ( 4.2A);ITI A   1 (-3.8A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A)","0.87A","3bbtD-3lzbA:37.8","3bbtD-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A 702;ALA A 719;LYS A 721;LEU A 764;ASP A 831;PHE A 832;LEU A 834","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 ( 4.2A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A);None","1.03A","3bbtD-3lzbA:37.8","3bbtD-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A 702;ALA A 719;LYS A 721;LEU A 764;THR A 766;ASP A 831;PHE A 832","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 ( 4.2A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A)","1.04A","3bbtD-3lzbA:37.8","3bbtD-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"VAL A 702;ALA A 719;MET A 742;LEU A 820;THR A 830;ASP A 831;PHE A 832;LEU A 834","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-3.4A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A);None","1.04A","3bbtD-3lzbA:37.8","3bbtD-3lzbA:69.82"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"VAL A 702;ALA A 719;MET A 742;THR A 766;LEU A 820;THR A 830;ASP A 831;PHE A 832","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-3.4A);ITI A   1 (-3.8A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);ITI A   1 (-3.6A)","1.00A","3bbtD-3lzbA:37.8","3bbtD-3lzbA:69.82"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A 719;LEU A 764;THR A 766;LEU A 768;MET A 769","ITI A   1 (-2.9A);ITI A   1 ( 4.2A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-4.8A)","0.82A","3lfaA-3lzbA:19.2","3bbtD-3lzbA:69.82"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A 719;LYS A 721;LEU A 764;THR A 766;LEU A 768","ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 ( 4.2A);ITI A   1 (-3.8A);ITI A   1 (-4.8A)","0.44A","3lfaA-3lzbA:19.2","3lfaA-3lzbA:23.75"],["3V5W_A_8PRA701_1","G-PROTEIN COUPLED RECEPTOR KINASE 2","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"GLY A 697;GLY A 700;VAL A 702;ALA A 719;LEU A 723;LEU A 820;ASP A 831","None;None;ITI A   1 (-4.8A);ITI A   1 (-2.9A);None;ITI A   1 (-4.6A);ITI A   1 ( 4.6A)","1.13A","3v5wA-3lzbA:7.5","3lfaA-3lzbA:23.75"],["3V5W_A_8PRA701_1","G-PROTEIN COUPLED RECEPTOR KINASE 2","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"GLY A 697;GLY A 700;VAL A 702;ALA A 719;LYS A 721;LEU A 723;ASP A 831","None;None;ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);None;ITI A   1 ( 4.6A)","1.11A","3v5wA-3lzbA:7.5","3v5wA-3lzbA:16.93"],["4HJO_A_AQ4A1001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"ALA A 719;THR A 766;MET A 769;GLY A 772;CYH A 773;LEU A 820;THR A 830;ASP A 831","ITI A   1 (-2.9A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);ITI A   1 (-4.8A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.95A","4hjoA-3lzbA:38.7","3v5wA-3lzbA:16.93"],["4HJO_A_AQ4A1001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"VAL A 702;ALA A 719;THR A 766;MET A 769;CYH A 773;LEU A 820;THR A 830;ASP A 831","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-4.8A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","1.03A","4hjoA-3lzbA:38.7","4hjoA-3lzbA:88.07"],["4LMN_A_EUIA503_1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",5,"LYS A 721;ASN A 818;ASP A 831;PHE A 832;GLY A 833","ITI A   1 (-2.6A);None;ITI A   1 ( 4.6A);ITI A   1 (-3.6A);None","0.92A","4lmnA-3lzbA:24.5","4hjoA-3lzbA:88.07"],["4WA9_A_AXIA9000_1","TYROSINE-PROTEIN KINASE ABL1","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 694;ALA A 719;THR A 766;GLY A 772;ASN A 818;LEU A 820","ITI A   1 (-3.9A);ITI A   1 (-2.9A);ITI A   1 (-3.8A);ITI A   1 (-3.5A);None;ITI A   1 (-4.6A)","0.68A","4wa9A-3lzbA:28.4","4lmnA-3lzbA:23.42"],["4WKQ_A_IREA1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"ALA A 719;LEU A 764;THR A 766;LEU A 768;GLY A 772;ASP A 776;LEU A 820;THR A 830","ITI A   1 (-2.9A);ITI A   1 ( 4.2A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);None;ITI A   1 (-4.6A);ITI A   1 (-3.8A)","0.88A","4wkqA-3lzbA:34.6","4wa9A-3lzbA:34.04"],["4WKQ_A_IREA1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 694;ALA A 719;LEU A 764;THR A 766;LEU A 768;GLY A 772;ASP A 776","ITI A   1 (-3.9A);ITI A   1 (-2.9A);ITI A   1 ( 4.2A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);None","0.98A","4wkqA-3lzbA:34.6","4wkqA-3lzbA:86.97"],["4WKQ_A_IREA1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 753;THR A 766;LEU A 768;GLY A 772;ASP A 776;LEU A 820;THR A 830","ITI A   1 (-3.8A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);None;ITI A   1 (-4.6A);ITI A   1 (-3.8A)","1.42A","4wkqA-3lzbA:34.6","4wkqA-3lzbA:86.97"],["4XOY_A_DX4A401_0","MITOGEN-ACTIVATED PROTEIN KINASE 1","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",4,"ALA A 719;LEU A 768;MET A 769;LEU A 820","ITI A   1 (-2.9A);ITI A   1 (-4.8A);ITI A   1 (-4.8A);ITI A   1 (-4.6A)","0.88A","4xoyA-3lzbA:20.7","4wkqA-3lzbA:86.97"],["4XP3_A_DX4A401_0","MITOGEN-ACTIVATED PROTEIN KINASE 1","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",4,"ALA A 719;LEU A 768;MET A 769;LEU A 820","ITI A   1 (-2.9A);ITI A   1 (-4.8A);ITI A   1 (-4.8A);ITI A   1 (-4.6A)","0.81A","4xp3A-3lzbA:21.0","4xoyA-3lzbA:22.40"],["5H2U_A_1N1A501_1","PROTEIN-TYROSINE KINASE 6","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 694;ALA A 719;THR A 766;LEU A 768;GLY A 772;LEU A 820","ITI A   1 (-3.9A);ITI A   1 (-2.9A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);ITI A   1 (-4.6A)","0.90A","5h2uA-3lzbA:32.1","4xp3A-3lzbA:22.40"],["5H2U_A_1N1A501_1","PROTEIN-TYROSINE KINASE 6","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 694;VAL A 702;ALA A 719;LYS A 721;THR A 766;LEU A 768;LEU A 820","ITI A   1 (-3.9A);ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-4.6A)","0.91A","5h2uA-3lzbA:32.1","5h2uA-3lzbA:30.03"],["5H2U_B_1N1B501_1","PROTEIN-TYROSINE KINASE 6","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 694;ALA A 719;THR A 766;LEU A 768;GLY A 772;LEU A 820;ASP A 831","ITI A   1 (-3.9A);ITI A   1 (-2.9A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-3.5A);ITI A   1 (-4.6A);ITI A   1 ( 4.6A)","1.00A","5h2uB-3lzbA:32.3","5h2uA-3lzbA:30.03"],["5H2U_B_1N1B501_1","PROTEIN-TYROSINE KINASE 6","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 694;VAL A 702;ALA A 719;LYS A 721;THR A 766;LEU A 768;LEU A 820;ASP A 831","ITI A   1 (-3.9A);ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 (-3.8A);ITI A   1 (-4.8A);ITI A   1 (-4.6A);ITI A   1 ( 4.6A)","0.99A","5h2uB-3lzbA:32.3","5h2uB-3lzbA:30.03"],["5HIE_C_P06C801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",5,"GLY A 695;VAL A 702;ALA A 719;LYS A 721;THR A 766","ITI A   1 ( 4.8A);ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 (-3.8A)","0.58A","5hieC-3lzbA:26.5","5h2uB-3lzbA:30.03"],["5IZF_E_AZ1E2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;6J9-ZEU-DAR-ACA-DAR-NH2","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",4,"GLY A 695;GLY A 697;LYS A 721;LEU A 723","ITI A   1 ( 4.8A);None;ITI A   1 (-2.6A);None","0.77A","5izfA-3lzbA:20.4","5hieC-3lzbA:27.14"],["5IZJ_F_AZ1F2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR-DAR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",5,"GLY A 695;GLY A 697;GLY A 700;VAL A 702;LEU A 723","ITI A   1 ( 4.8A);None;None;ITI A   1 (-4.8A);None","0.76A","5izjB-3lzbA:20.1","5izfA-3lzbA:22.86"],["5IZJ_G_AZ1G2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",4,"GLY A 695;GLY A 697;VAL A 702;LYS A 721","ITI A   1 ( 4.8A);None;ITI A   1 (-4.8A);ITI A   1 (-2.6A)","0.44A","5izjA-3lzbA:20.2","5izjB-3lzbA:22.86"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",5,"GLY A 695;VAL A 702;ALA A 719;LEU A 768;LEU A 820","ITI A   1 ( 4.8A);ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-4.8A);ITI A   1 (-4.6A)","0.92A","5lw1H-3lzbA:19.3","5izjA-3lzbA:22.86"],["5MAF_A_XINA403_2","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",4,"LEU A 753;CYH A 751;LEU A 820;ASP A 831","ITI A   1 (-3.8A);ITI A   1 (-3.7A);ITI A   1 (-4.6A);ITI A   1 ( 4.6A)","1.46A","5mafA-3lzbA:22.9","5lw1H-3lzbA:12.59"],["5YU9_A_1E8A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",10,"LEU A 694;GLY A 695;VAL A 702;ALA A 719;LYS A 721;MET A 742;LEU A 764;CYH A 773;THR A 830;ASP A 831","ITI A   1 (-3.9A);ITI A   1 ( 4.8A);ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 (-3.4A);ITI A   1 ( 4.2A);ITI A   1 (-4.8A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.79A","5yu9A-3lzbA:39.0","5mafA-3lzbA:11.55"],["5YU9_A_1E8A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",10,"LEU A 694;GLY A 695;VAL A 702;ALA A 719;MET A 742;LEU A 764;CYH A 773;LEU A 820;THR A 830;ASP A 831","ITI A   1 (-3.9A);ITI A   1 ( 4.8A);ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-3.4A);ITI A   1 ( 4.2A);ITI A   1 (-4.8A);ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.76A","5yu9A-3lzbA:39.0","5yu9A-3lzbA:95.00"],["5YU9_B_1E8B1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",11,"GLY A 695;VAL A 702;ALA A 719;LYS A 721;MET A 742;LEU A 764;CYH A 773;ASP A 776;LEU A 820;THR A 830;ASP A 831","ITI A   1 ( 4.8A);ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 (-3.4A);ITI A   1 ( 4.2A);ITI A   1 (-4.8A);None;ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.69A","5yu9B-3lzbA:38.9","5yu9A-3lzbA:95.00"],["5YU9_C_1E8C1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",9,"ALA A 719;LYS A 721;MET A 742;LEU A 764;GLY A 772;CYH A 773;ASP A 776;THR A 830;ASP A 831","ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 (-3.4A);ITI A   1 ( 4.2A);ITI A   1 (-3.5A);ITI A   1 (-4.8A);None;ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.76A","5yu9C-3lzbA:38.9","5yu9B-3lzbA:95.00"],["5YU9_C_1E8C1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 753;GLY A 772;CYH A 773;ASP A 776;THR A 830;ASP A 831","ITI A   1 (-3.8A);ITI A   1 (-3.5A);ITI A   1 (-4.8A);None;ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","1.29A","5yu9C-3lzbA:38.9","5yu9C-3lzbA:95.00"],["5YU9_C_1E8C1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",9,"VAL A 702;ALA A 719;LYS A 721;MET A 742;LEU A 764;CYH A 773;ASP A 776;THR A 830;ASP A 831","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 (-3.4A);ITI A   1 ( 4.2A);ITI A   1 (-4.8A);None;ITI A   1 (-3.8A);ITI A   1 ( 4.6A)","0.75A","5yu9C-3lzbA:38.9","5yu9C-3lzbA:95.00"],["5YU9_D_1E8D1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",10,"ALA A 719;LYS A 721;MET A 742;GLY A 772;CYH A 773;ASP A 776;LEU A 820;THR A 830;ASP A 831;LEU A 834","ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 (-3.4A);ITI A   1 (-3.5A);ITI A   1 (-4.8A);None;ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);None","0.79A","5yu9D-3lzbA:39.0","5yu9C-3lzbA:95.00"],["5YU9_D_1E8D1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3lzb","EPIDERMAL GROWTH FACTOR RECEPTOR","Homo sapiens",10,"VAL A 702;ALA A 719;LYS A 721;MET A 742;CYH A 773;ASP A 776;LEU A 820;THR A 830;ASP A 831;LEU A 834","ITI A   1 (-4.8A);ITI A   1 (-2.9A);ITI A   1 (-2.6A);ITI A   1 (-3.4A);ITI A   1 (-4.8A);None;ITI A   1 (-4.6A);ITI A   1 (-3.8A);ITI A   1 ( 4.6A);None","0.80A","5yu9D-3lzbA:39.0","5yu9D-3lzbA:95.00"]]